Product
Linagliptin + Metformin
2 clinical trials
3 indications
Indication
Healthy Control ParticipantsIndication
Type 2 Diabetes MellitusIndication
Nonalcoholic Fatty Liver DiseaseClinical trial
Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of GC2129A in Healthy Adult Volunteers Under Fed ConditionsStatus: Recruiting, Estimated PCD: 2023-04-17
Clinical trial
Effect of Henagliflozein on Hepatic Fat Content in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized, Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2026-11-01